Vanguard Group’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29M | Buy |
|
|||||
|
2025
Q1 | $852K | Hold |
|
|||||
|
2024
Q4 | $1.03M | Sell |
|
|||||
|
2024
Q3 | $693K | Sell |
|
|||||
|
2024
Q2 | $581K | Sell |
|
|||||
|
2024
Q1 | $2.26M | Sell |
|
|||||
|
2023
Q4 | $1.95M | Buy |
|
|||||
|
2023
Q3 | $4.37M | Buy |
|
|||||
|
2023
Q2 | $7.34M | Sell |
|
|||||
|
2023
Q1 | $15.3M | Buy |
|
|||||
|
2022
Q4 | $33.3M | Sell |
|
|||||
|
2022
Q3 | $31M | Buy |
|
|||||
|
2022
Q2 | $29.8M | Buy |
|
|||||
|
2022
Q1 | $39.4M | Buy |
|
|||||
|
2021
Q4 | $36.9M | Buy |
|
|||||
|
2021
Q3 | $46.5M | Buy |
|
|||||
|
2021
Q2 | $39.2M | Buy |
|
|||||
|
2021
Q1 | $48.9M | Sell |
|
|||||
|
2020
Q4 | $34.2M | Buy |
|
|||||
|
2020
Q3 | $28.5M | Sell |
|
|||||
|
2020
Q2 | $38.6M | Sell |
|
|||||
|
2020
Q1 | $30.1M | Buy |
|
|||||
|
2019
Q4 | $35M | Sell |
|
|||||
|
2019
Q3 | $39.7M | Buy |
|
|||||
|
2019
Q2 | $38.3M | Buy |
|
|||||
|
2019
Q1 | $34.6M | Buy |
|
|||||
|
2018
Q4 | $21.4M | Buy |
|
|||||
|
2018
Q3 | $37.2M | Buy |
|
|||||
|
2018
Q2 | $23.9M | Buy |
|
|||||
|
2018
Q1 | $15.2M | Buy |
|
|||||
|
2017
Q4 | $14.9M | Buy |
|
|||||
|
2017
Q3 | $16.2M | Buy |
|
|||||
|
2017
Q2 | $17.1M | Buy |
|
|||||
|
2017
Q1 | $17.4M | Buy |
|
|||||
|
2016
Q4 | $7.31M | Buy |
|
|||||
|
2016
Q3 | $6.04M | Buy |
|
|||||
|
2016
Q2 | $3.23M | Sell |
|
|||||
|
2016
Q1 | $4.28M | Buy |
|
|||||
|
2015
Q4 | $11.1M | Buy |
|
|||||
|
2015
Q3 | $7.68M | Buy |
|
|||||
|
2015
Q2 | $3.47M | Buy |
|
|||||
|
2015
Q1 | $2.33M | Buy |
|
|||||
|
2014
Q4 | $1.75M | Sell |
|
|||||
|
2014
Q3 | $1.47M | Sell |
|
|||||
|
2014
Q2 | $4.12M | Buy |
|
|||||
|
2014
Q1 | $1.79M | Buy |
|